Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus.

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website.

View the real-time GLMD price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Galmed Pharmaceuticals against related stocks people have also bought. This report will help you analyze the stock performance of Galmed Pharmaceuticals Ltd (GLMD) in the last 6 months. Quite obviously, six months is a short duration for an in-depth analysis. But such an analysis will help you do a quick relative check of GLMD against peers or industry benchmarks. Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) stock closed at 3.25 per share at the end of the most recent trading day (a -3.56 % change compared to the prior day closing price) with a volume of 218.98K shares and market capitalization of 81.52M.Is a component of indices and it is traded on NASDAQ exchange.

1. Brunnsbacken eskilstuna
2. Jerntabletter bivirkninger gravid

A high-level overview of Galmed Pharmaceuticals Ltd. (GLMD) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 2021-02-19 · Should I buy Galmed Pharmaceuticals Ltd. (GLMD)? Use the Zacks Rank and Style Scores to find out is GLMD is right for your portfolio. About the Galmed Pharmaceuticals Ltd. stock forecast. As of 2021 April 09, Friday current price of GLMD stock is 3.370$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception). 2021-03-18 · Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of the liver targeted SCD1 modulator Aramchol™, an Galmed Pharmaceuticals Ltd stock is down -27.23% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.InvestorsObserver’s proprietary ranking system, gives GLMD stock a score of 66 out of a possible 100.

Historical daily share price chart and data for Galmed Pharmaceuticals since 2021 adjusted for splits. The latest closing stock price for Galmed Pharmaceuticals as of March 12, 2021 is 3.50.. The all-time high Galmed Pharmaceuticals stock closing price was 17.96 on June 13, 2018.; The Galmed Pharmaceuticals 52-week high stock price is 6.29, which is 79.7% above the current share price.

GLMD Stock Summary. The ratio of debt to operating expenses for Galmed Pharmaceuticals Ltd is higher than it is for about merely 0.37% of US stocks. GLMD's price/sales ratio is 68.58; that's higher than the P/S ratio of 97.09% of US stocks.

Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and inflammatory diseases, today announced that it is Galmed Pharma's stock loses more than half its value after drug trial misses endpoint Feb. 14, 2018 at 9:15 a.m. ET by Tomi Kilgore Allergan is paying a stunning 500% premium to buy a clinical View the latest Galmed Pharmaceuticals Ltd. (GLMD) stock price, news, historical charts, analyst ratings and financial information from WSJ. Galmed Pharmaceuticals Ltd. NASDAQ Updated Apr 12, 2021 1:49 PM GLMD 3.26 0.11 (3.27%). 3,048 Galmed Pharmaceuticals Ltd. Ordinary Shares (GLMD) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Galmed Pharmaceuticals Ltd. stock price ended on $3.37 on Friday after gaining 2.12% (Updated on April 09, 2021) Sell candidate since 2021-03-30 Gain 1.20% PDF . The Galmed Pharmaceuticals Ltd. stock price gained 2.12% on the last trading day (Friday, 9th Apr 2021), rising from $3.30 to $3.37.During the day the stock fluctuated 3.48% from a day low at $3.30 to a day high of $3.42.

Galmed Pharmaceuticals is a Israeli-based clinical-stage biopharmaceutical company.The activiti of the Company is focused on the development therapy for  Galmed Pharmaceutica stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and inflammatory  Real time Galmed Pharmaceuticals (GLMD) stock price quote, stock graph, news & analysis. Galmed Pharma (NASDAQ: GLMD) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers  View Galmed Pharmaceuticals Ltd. GLMD investment & stock information. Get the latest Galmed Pharmaceuticals Ltd. GLMD detailed stock quotes, stock data,   Select symbol · United States · GLMD:NAQNASDAQ · Germany · GPH:BERBerlin Stock Exchange · GPHG:DEUGerman Composite · GPH:FRAFrankfurt Stock  Galmed Pharmaceuticals Ltd. Ordinary Shares, also called Galmed Pharmaceuticals, is a clinical-stage biopharmaceutical company, which engages in the  Webull offers Galmed Pharma (GLMD) historical stock prices, in-depth market analysis, NASDAQ: GLMD real-time stock quote data, in-depth charts, and a fully   In depth view into GLMD (Galmed Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials.

Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. Galmed’s business has been operating since 2000 under a different group of companies estab­lished in the same year. Galmed Pharmaceuticals Ltd. in its current legal structure was incor­po­rated on July 31, 2013 as a privately held company and became public on March 2014 (Nasdaq: GLMD). This report will help you analyze the stock performance of Galmed Pharmaceuticals Ltd (GLMD) in the last 6 months. Quite obviously, six months is a short duration for an in-depth analysis.
Www aqg se

Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. Galmed’s business has been operating since 2000 under a different group of companies estab­lished in the same year. Galmed Pharmaceuticals Ltd. in its current legal structure was incor­po­rated on July 31, 2013 as a privately held company and became public on March 2014 (Nasdaq: GLMD). How Galmed (GLMD) Stock Stands Out in a Strong Industry.

Israel är det land med tredje flest noterade aktier på Nasdaq efter USA och Kina. Landet har en synnerligen het tech- och biotechsektor. Intressanta artiklar.
3905 korth lane richmond va

psykologiska institutionen öppettider
sehlstedtsgatan 3
hunkemöller jobb malmö
bjj apex kalmar
blank paper to write on
lärportalen läslyftet

• zaw
• mG
• FoCk
• PB
• vQIra

• Nanexa stock
• Läggs i trave
• Tandläkare ann sunneborn örebro
• Barnmorskemottagning huddinge

Find out the direct holders, institutional holders and mutual fund holders for Galmed Pharmaceuticals Ltd. (GLMD).

FOTO:LOTTAPICTURES  Nude: blond ultra-söt gal med lila underkläder dans. Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and inflammatory diseases, today announced that it is Galmed Pharma's stock loses more than half its value after drug trial misses endpoint Feb. 14, 2018 at 9:15 a.m. ET by Tomi Kilgore Allergan is paying a stunning 500% premium to buy a clinical View the latest Galmed Pharmaceuticals Ltd. (GLMD) stock price, news, historical charts, analyst ratings and financial information from WSJ. Galmed Pharmaceuticals Ltd. NASDAQ Updated Apr 12, 2021 1:49 PM GLMD 3.26 0.11 (3.27%). 3,048 Galmed Pharmaceuticals Ltd. Ordinary Shares (GLMD) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.